# Sources — Gregory Boyington pilot

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 1, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. United States Marine Corps History Division. “Major Gregory Boyington.” Government biography supporting birth, service, Medal of Honor, January 3, 1944 loss, and approximately 20 months as a prisoner of war. https://www.usmcu.edu/Research/Marine-Corps-History-Division/People/Medal-of-Honor-Recipients-By-Unit/Maj-Gregory-Boyington/
2. United States Marine Corps. “69 years ago today, legendary WWII ace makes final flight.” Government account supporting capture, beatings, interrogation, near-starvation, repatriation, and decoration. https://www.marines.mil/News/News-Display/Article/522954/69-years-ago-today-legendary-wwii-ace-makes-final-flight/
3. Bossert, Phil Jr. Review of Bruce Gamble, *Black Sheep One: The Life of Gregory ‘Pappy’ Boyington*. *Aerospace Power Journal* (Winter 2001), pp. 106–108. The military scholarly review describes longstanding alcohol-related impairment, long sober periods, and later relapses. https://www.airuniversity.af.edu/Portals/10/ASPJ/journals/Volume-15_Issue-1-4/win01.pdf
4. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021). https://www.healthquality.va.gov/guidelines/MH/sud/
2. VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023). https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/ptsd/
3. VA National Center for PTSD. “Treatment of Co-Occurring PTSD and Substance Use Disorder in VA.” Supports concurrent, patient-centered treatment rather than requiring one disorder to resolve first. https://www.ptsd.va.gov/professional/treat/cooccurring/tx_sud_va.asp
4. National Institute on Alcohol Abuse and Alcoholism. “Recommend Evidence-Based Treatment: Know the Options.” Supports shared decision-making among behavioral treatment, medications, and mutual support. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/recommend-evidence-based-treatment-know-options
5. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), depression monograph. Used for the PHQ-9 cadence and the suicide-risk reassessment at every visit in the focused visits; no depressive disorder is diagnosed. https://patrickrutledge.github.io/topthirty/
6. Qaseem A, Wilt TJ, McLean RM, Forciea MA. “Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.” *Ann Intern Med* 2017;166(7):514–530; and the VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain (2022). Cited for the sick visit: no imaging without red flags, staying active, superficial heat, and an NSAID as the first drug choice. https://pubmed.ncbi.nlm.nih.gov/28192789/ and https://www.healthquality.va.gov/guidelines/pain/lbp/
7. U.S. Preventive Services Task Force recommendations used at the adult preventive visit for a 44-year-old man: Depression and Suicide Risk in Adults: Screening (2023); Unhealthy Drug Use: Screening (2020); Tobacco Smoking Cessation in Adults (2021); Hypertension in Adults: Screening (2021); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (2022); Prediabetes and Type 2 Diabetes: Screening (2021); HIV Infection: Screening (2019); Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020); and Colorectal Cancer: Screening (2021). The URLs are in `case.json`.
8. Centers for Disease Control and Prevention. “Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023.” *MMWR Recomm Rep* 2023;72(1). https://pubmed.ncbi.nlm.nih.gov/36893044/
9. Kobayashi M, et al. “Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices, United States, 2022.” *MMWR* 2022;71(4):109–117. Alcoholism is a risk indication for pneumococcal conjugate vaccine in adults 19 to 64. https://pubmed.ncbi.nlm.nih.gov/35085226/ The CDC adult schedule page returned an access error and is not cited as a guideline record.
10. Medicare Preventive Services reference (Aether Forge, 2026): visit templates and documentation elements, used for the structure of the preventive note. https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- The roster phrase “eventual sobriety” is not retained as an unqualified fact. The stronger source describes both sustained sober periods and relapse.
- PTSD remains evidence grade **R** because no lifetime contemporary diagnosis has been established.
- Alcohol use disorder and PTSD in the modern episode are grade **S** provisional diagnoses used for interoperability and care-plan testing.
- Captivity abuse is described without graphic detail. No self-harm history is inferred.
- Boyington died in 1988, so the project’s recent-death review rule does not apply; ordinary clinical, provenance, and safe-messaging reviews remain required.
- **Review reopened.** The pilot was approved on November 2, 2026. Adding the focused visits, a sick visit, a preventive visit, and the consultation reopened clinical and safe-messaging review on November 3, 2026, and the release status returned to draft. Provenance review and the claim release statuses are unchanged, because no historical claim was added or changed.
- **Focused visits.** The six-week (ENC-002) and three-month (ENC-003) follow-ups are documented as focused visits. Alcohol use disorder and PTSD are not CMID conditions, so their protocol rows follow the VA/DoD SUD (2021) and PTSD (2023) guidelines and the NIAAA options page the case already cited: AUDIT-C and PCL-5 at each review, trauma-focused psychotherapy, the recovery peer group and relapse plan, the offer of medication for alcohol use disorder, avoiding benzodiazepines and sedative-hypnotics, blood pressure, weight, signs of withdrawal or liver disease, and sleep. The CMID depression monograph supplies the PHQ-9 cadence and the suicide-risk reassessment at every visit, which reviews the intake safety assessment and safety plan. Synthetic findings introduced: drinking patterns consistent with each AUDIT-C score (one heavy-drinking day in the third week of therapy, in late July, managed with the relapse plan), prolonged exposure as the trauma-focused therapy (nine sessions, matching GOAL-003 and PRC-001), nightmare frequency and sleep hours, PHQ-9 item 9 scored 0 at every visit, and the physical and mental status findings. No medication was started; naltrexone and acamprosate were offered again and declined, consistent with INT-002. **Protocol deviation recorded:** no hepatic panel or GGT was drawn at intake despite heavy drinking. The six-week note records it as deferred (no medication depended on it and there was no sign of liver disease), the three-month note as due, and the preventive visit orders it. No result is invented.
- **Sick and preventive visits.** An unscheduled sick visit (ENC-004) falls on October 9, 2026 (true frame October 9, 1957) for an acute lumbar muscle strain after lifting, and an adult preventive visit (ENC-005) on October 28, 2026 (true frame October 28, 1957). Both keep the index age of 44, fall long before the 1988 death, and contradict no documented event. The strain is synthetic, resolved within ten days, and does not echo a documented illness or injury. It was chosen because it interacts with the case: alcohol with NSAIDs and acetaminophen, the avoidance of sedating muscle relaxants and opioids in alcohol use disorder, and pain-broken sleep that brought a nightmare and a craving, managed with the relapse plan. The preventive visit records PHQ-9 2 (item 9 scored 0, consistent with the safety assessment) and AUDIT-C 1, gives this season's influenza vaccine and PCV20 (alcohol use disorder is a risk indication), and orders the hepatic panel, GGT, HbA1c, lipid panel, and HIV, hepatitis C, and hepatitis B screening, with no results recorded. Colorectal cancer screening becomes due at 45, in December.
- **Consultation.** The behavioral health referral (Dr. Marquez, at intake) and consultation (Marcus Lee, PsyD, a fictional consultant, on the day of the six-week visit) are **S**. Because the referral starts the psychotherapy in PRC-001, the consultation note is written after five sessions and reports the intake diagnostic interview, a mental status examination, and a risk assessment (low acute risk, with chronic risk factors and protective factors listed). Its recommendations are what the record then shows: prolonged exposure to completion (about four more sessions, nine in all), behavioral alcohol treatment with medication revisited only if heavy drinking recurred (it did not), no benzodiazepines, repeat measures at twelve weeks, and sleep advice with cognitive behavioral therapy for insomnia only if needed (it was not). Captivity is referred to without detail.
